ATYR PHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.57 USD | -1.57% |
|
-1.88% | +11.35% |
| Mar. 15 | RBC Cuts Price Target on aTyr Pharma to $16 From $19, Keeps Outperform Rating, Speculative Risk Qualifier | MT |
| Mar. 14 | Transcript : ATyr Pharma, Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Neutral |
| Resistance | 1.770 | 2.020 | 2.450 |
| Spread/Res. | -11.30% | -22.28% | -35.92% |
| Spread/Supp. | +10.56% | +10.56% | +40.18% |
| Support | 1.420 | 1.420 | 1.120 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- LIFE Stock
- Charts aTyr Pharma, Inc.
